139 related articles for article (PubMed ID: 19639209)
41. Glutathione transferase-A2 S112T polymorphism predicts survival, transplant-related mortality, busulfan and bilirubin blood levels after allogeneic stem cell transplantation.
Bonifazi F; Storci G; Bandini G; Marasco E; Dan E; Zani E; Albani F; Bertoni S; Bontadini A; De Carolis S; Sapienza MR; Rizzi S; Motta MR; Ferioli M; Garagnani P; Cavo M; Mantovani V; Bonafè M
Haematologica; 2014 Jan; 99(1):172-9. PubMed ID: 24056816
[TBL] [Abstract][Full Text] [Related]
42. [Association of single nucleotide polymorphisms and haplotypes in DNA repair gene XRCC1 with susceptibility of breast cancer].
Jin MJ; Chen K; Zhang SS; Zhang YJ; Ren YJ; Xu H; Yao KY; Li QL; Ma XY
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 35(4):370-6. PubMed ID: 16924699
[TBL] [Abstract][Full Text] [Related]
43. CYP17, catechol-o-methyltransferase, and glutathione transferase M1 genetic polymorphisms, lifestyle factors, and breast cancer risk in women on Prince Edward Island.
Cribb AE; Joy Knight M; Guernsey J; Dryer D; Hender K; Shawwa A; Tesch M; Saleh TM
Breast J; 2011; 17(1):24-31. PubMed ID: 21129090
[TBL] [Abstract][Full Text] [Related]
44. The rs3957357C>T SNP in GSTA1 Is Associated with a Higher Risk of Occurrence of Hepatocellular Carcinoma in European Individuals.
Akhdar H; El Shamieh S; Musso O; Désert R; Joumaa W; Guyader D; Aninat C; Corlu A; Morel F
PLoS One; 2016; 11(12):e0167543. PubMed ID: 27936036
[TBL] [Abstract][Full Text] [Related]
45. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
[TBL] [Abstract][Full Text] [Related]
46. Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women.
Huang Y; Trentham-Dietz A; García-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1321-3. PubMed ID: 19293312
[TBL] [Abstract][Full Text] [Related]
47. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
Saxena A; Dhillon VS; Raish M; Asim M; Rehman S; Shukla NK; Deo SV; Ara A; Husain SA
Breast Cancer Res Treat; 2009 Jun; 115(3):537-43. PubMed ID: 18574688
[TBL] [Abstract][Full Text] [Related]
48. Glutathione S-transferase mu polymorphism and susceptibility to lung cancer in the Portuguese population.
Moreira A; Martins G; Monteiro MJ; Alves M; Dias J; da Costa JD; Melo MJ; Matias D; Costa A; Cristóvão M; Rueff J; Monteiro C
Teratog Carcinog Mutagen; 1996; 16(5):269-74. PubMed ID: 9122892
[TBL] [Abstract][Full Text] [Related]
49. Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy.
Sgambato A; Campisi B; Zupa A; Bochicchio A; Romano G; Tartarone A; Galasso R; Traficante A; Cittadini A
Anticancer Res; 2002; 22(6B):3647-52. PubMed ID: 12552971
[TBL] [Abstract][Full Text] [Related]
50. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs?
Coles BF; Kadlubar FF
Biofactors; 2003; 17(1-4):115-30. PubMed ID: 12897434
[TBL] [Abstract][Full Text] [Related]
51. Effects of glutathione-S-transferase polymorphisms on the risk of breast cancer: a population-based case-control study in Pakistan.
Sohail A; Kanwal N; Ali M; Sadia S; Masood AI; Ali F; Iqbal F; Crickmore N; Shaikh RS; Sayyed AH
Environ Toxicol Pharmacol; 2013 Mar; 35(2):143-53. PubMed ID: 23376175
[TBL] [Abstract][Full Text] [Related]
52. Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.
Reding KW; Weiss NS; Chen C; Li CI; Carlson CS; Wilkerson HW; Farin FM; Thummel KE; Daling JR; Malone KE
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1461-7. PubMed ID: 19383894
[TBL] [Abstract][Full Text] [Related]
53. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
[TBL] [Abstract][Full Text] [Related]
54. HapMap-based study of human soluble glutathione S-transferase enzymes: the role of natural selection in shaping the single nucleotide polymorphism diversity of xenobiotic-metabolizing genes.
Polimanti R; Piacentini S; Fuciarelli M
Pharmacogenet Genomics; 2011 Oct; 21(10):665-72. PubMed ID: 21799460
[TBL] [Abstract][Full Text] [Related]
55. Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype.
Spurdle AB; Webb PM; Purdie DM; Chen X; Green A; Chenevix-Trench G
Carcinogenesis; 2001 Jan; 22(1):67-72. PubMed ID: 11159743
[TBL] [Abstract][Full Text] [Related]
56. hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a caucasian population.
Wikman H; Risch A; Klimek F; Schmezer P; Spiegelhalder B; Dienemann H; Kayser K; Schulz V; Drings P; Bartsch H
Int J Cancer; 2000 Dec; 88(6):932-7. PubMed ID: 11093817
[TBL] [Abstract][Full Text] [Related]
57. Single nucleotide polymorphism of pi-class glutathione s-transferase and susceptibility to endometrial carcinoma.
Chan QK; Khoo US; Ngan HY; Yang CQ; Xue WC; Chan KY; Chiu PM; Ip PP; Cheung AN
Clin Cancer Res; 2005 Apr; 11(8):2981-5. PubMed ID: 15837751
[TBL] [Abstract][Full Text] [Related]
58. Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.
Gaudet MM; Chanock S; Lissowska J; Berndt SI; Yang XR; Peplonska B; Brinton LA; Welch R; Yeager M; Bardin-Mikolajczak A; Sherman ME; Sutter TR; Garcia-Closas M
Pharmacogenet Genomics; 2006 Aug; 16(8):547-53. PubMed ID: 16847423
[TBL] [Abstract][Full Text] [Related]
59. Genetic polymorphism of drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in North India.
Mittal RD; Srivastava DS; A M; B M
Asian Pac J Cancer Prev; 2005; 6(1):6-9. PubMed ID: 15780023
[TBL] [Abstract][Full Text] [Related]
60. Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans.
Bailey LR; Roodi N; Verrier CS; Yee CJ; Dupont WD; Parl FF
Cancer Res; 1998 Jan; 58(1):65-70. PubMed ID: 9426059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
